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ABSTRACT
The mechanisms of influenza A virus mRNA intracel-
lular transport are still not clearly understood. Here,
we visualized the distribution and transport of influ-
enza A virus mRNA in living cells using molecular
beacon (MB) technology. Confocal-FRAP measure-
ments determined that the transport of influenza A
virus intronless mRNA, in both nucleus and cyto-
plasm, was energy dependent, being similar to that
of Poly(A)
+ RNA. Drug inhibition studies in living
cells revealed that the export of influenza A virus
mRNA is independent of the CRM1 pathway, while
the function of RNA polymerase II (RNAP-II) may be
needed. In addition, viral NS1 protein and cellular
TAP protein were found associated with influenza
A virus mRNA in the cell nucleus. These findings
characterize influenza A virus mRNA transport in
living cells and suggest that influenza A virus
mRNA may be exported from the nucleus by the
cellular TAP/p15 pathway with NS1 protein and
RNAP-II participation.
INTRODUCTION
Inﬂuenza virus is one of the few RNA viruses to synthesize
its mRNA in the nucleus of infected cells (1). The virus
mRNAs are potential substrates for the cellular splicing
machinery and need to be exported from the nucleus to
enable the viral proteins to be synthesized (2). Uncovering
the mechanisms of inﬂuenza virus mRNA export is of
great importance to truly understand the replication and
pathogenicity of the virus. The nuclear export of cellular
mRNA is mediated by several proteins that bind to
mRNA and to pre-mRNA precursors (3). However,
unlike cellular intron-containing mRNAs, most inﬂuenza
virus mRNAs are intronless. Hence, the export mecha-
nisms of viral intronless mRNAs might be diﬀerent from
those of cellulr mRNAs. Moreover, because there are three
diﬀerent types of inﬂuenza virus mRNA, more than one
mechanism of nuclear export might operate in virus-
infected cells (1). The ﬁrst type of inﬂuenza virus mRNA
includes intronless mRNAs, such as PA, PB1, PB2, HA,
NA and NP mRNA. The second type of viral mRNA con-
sistsoftheM1andNS1mRNAs,whichcontainintronsbut
do not undergo splicing. The M2 and NS2 mRNAs, which
are produced by splicing, comprise the third type of viral
mRNA. The mechanisms of the nuclear export of these
three types of inﬂuenza A virus mRNA remain unknown.
Two pathways have been described that appear to be
responsible for the export of viral mRNA (4). The ﬁrst
RNA export pathway was the CRM1 pathway, which is
utilized by human immunodeﬁciency virus (HIV) through
the mediation of the Rev protein (5). Herpes simplex virus
(HSV) also utilizes CRM1 to export its mRNA (6).
However, other studies showed that CRM1 may be not a
major contributor to mRNA export in metazoans or yeast
(7,8). The human protein TAP, and its yeast ortholog
Mex67p, might be the best candidates for mRNA export
receptors because they shuttle between the nucleus and
cytoplasm, cross-link to poly(A)
+ RNA, localize at the
nuclear pores and interact directly with nucleoporins
(9–12). The TAP pathway was reported to be used
by HSV ICP27 to export its intronless mRNAs (4).
Moreover, TAP protein could also promote the export of
constitutive transport element (CTE) containing tran-
scripts of some virus such as type D retrovirus (9,10,13).
Inﬂuenza A virus mRNA may, therefore, be exported from
the nucleus by the CRM1 dependent pathway or by the
TAP/p15 pathway. Previous studies have shown that inﬂu-
enza virus NS1 protein could selectively inhibit cellular
mRNA export by binding with CPSF and PABII (1), or
by forming an inhibitory complex with cellular mRNA
export factors TAP and p15 (14). Moreover, NS1 can
also inhibit the splicing and export of its own mRNA, in
an RNA binding-dependent manner (2). Nevertheless, the
mechanisms by which inﬂuenza virus mRNAs are exported
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inﬂuenza A virus intronless mRNA export are still unclear.
The ability to accurately and repeatedly track mRNA in
living mammalian cells would help us to fully understand
the mRNA transport mechanism. There are a variety of
tools currently used to visualize intracellular mRNAs,
including molecular beacons (MBs) and ﬂuorescently
labeled oligonucleotide probes. MBs are a powerful and
simple tool for cellular mRNA and viral RNA visualiza-
tion in living cells (15–21). Live-cell imaging of mRNA
could shed light on many fundamental processes, such
as the kinetics of mRNA production, mRNA localization
and transportation inside a cell and cellular responses to
virus infection and to virus–host interaction. We, there-
fore, used MBs as a detection probe to track inﬂuenza A
virus mRNA in living host cells, in order to explore the
mechanisms of viral mRNA export.
In this study, we successfully visualized inﬂuenza A
virus mRNA in living mammalian cells, and studied the
dynamic behaviors of inﬂuenza virus mRNA by Confocal-
FRAP experiments. By imaging experiments of living cells
and protein immunoﬂuorescence analysis in ﬁxed cells, it
was found that inﬂuenza A virus mRNAs could colocalize
with viral NS1 and cellular TAP protein in cell nucleus.
Moreover, coimmunoprecipitation experiments of inﬂu-
enza A virus mRNAs with NS1 and TAP protein revealed
that NS1 and TAP protein could be physically associated
with both intron-containing and intronless mRNAs of
inﬂuenza A virus. By performing Actinomycin D (ActD)
inhibition experiments in living cells we observed that
RNA polymerase II (RNAP-II) and other factors might
be involved in inﬂuenza virus mRNA export.
Furthermore, Leptomycin B (LMB), a speciﬁc inhibitor
of CRM1, could not inhibit inﬂuenza A virus mRNA
export in living cells. Therefore, inﬂuenza A virus
mRNA export may be independent of CRM1. Together,
these results indicate that the cellular transport of inﬂu-
enza A virus mRNA may be energy dependent and utilize
the cellular TAP/p15 transport pathway with the partici-
pation of viral NS1 protein and cellular RNAP-II.
MATERIALS AND METHODS
Cells,viruses, recombinant plasmids and other compounds
Inﬂuenza virus strains A/PR/8/34 (PR/8) was propagated
in 10-day-old embryonated eggs for 3 days at 36.58C.
MDCK cells were grown in RPM1640 medium supple-
mented with 10% FBS, 100U/ml of penicillin and
100mg/ml of streptomycin. The 293T cells were grown in
DMEM medium containing 10% FBS, 100U/ml of peni-
cillin and 100mg/ml of streptomycin. Plasmid pEGFP-C1-
NS1, which expresses the inﬂuenza virus strain PR/8 NS1
gene, was constructed by ligating NS1 cDNA in frame
into vector pEGFP-C1. Plasmid pCDNA3.1-TAP-GFP
was constructed by inserting the TAP gene, from PCS2-
FLAG-TAP [kindly provided by Prof. R.M. Sandri-
Goldin (University of California, Irvine, USA)] into
vector pCDNA3.1-GFP. Full-length NS1 gene and TAP
gene were also cloned into pCDNA3.1 vector. Rabbit
anti-NS1 polyclonal antibody was generously provided
by Prof. J. Ortı´n [Centro Nacional de Biotecnology ´ ’a
(CSIC), Madrid, Spain]. Mouse anti-TAP monoclonal
antibody was purchased from Abcam (Jingmei, China).
ActD (Sigma-Aldrich, St. Louis, MO, USA) was solubi-
lized in DMSO to a stock of 1mg/ml and used at 0.5mg/
ml. LMB (Sigma-Aldrich) was used at a concentration of
10nM. Energy depletion experiments were performed by
incubating cells in 20mM 2-deoxy-D-glucose (Sigma-
Aldrich) and 10mM sodium azide for 15–30min at 378C.
Transfection and influenza Avirus infection
For transfection and infection, cells were grown on cover-
slips placed on 35mm dishes. Transfections were per-
formed with Lipofectmine 2000 (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer’s instructions.
For virus infection, Inﬂuenza A virus [A/Puerto Rico/8/
34(H1N1)] propagation solution was diluted in PBS
(0.01M, pH 7.4), containing 0.2% bovine serum albumin,
and virus was added over cells at the indicated multiplicity
of infection (MOI), then adsorbed for 60min at 378C.
After removing the virus dilution, cells were maintained
in infecting media (RPMI 1640, 4ug/ml trypsin) at 378Ci n
5% CO2.
Probe design,synthesis and delivery into livingcells
Probes were designed based on genome sequence and
structure of Inﬂuenza A virus [A/Puerto Rico/8/
34(H1N1)] mRNAs using RNAdraw, Primer Premier 5.0
and NCBI BLAST. Probes speciﬁc to PR/8 mRNAs were
synthesized and puriﬁed by Shanghai Sangon (Shanghai,
China). The sequences of the MBs and control probes used
in this study and the location of diﬀerent labels are indi-
cated in Table 1.
MBs targeting inﬂuenza A virus mRNAs, as well as
control probes were delivered into living cells using a
reversible permeabilization method with streptolysin O
(SLO), as described previously (17,22,23). Speciﬁcally,
SLO was activated ﬁrst by adding 10mM of dithiothreitol
(DTT) to 1000U/ml of SLO for 90min at 378C. Cells
grown in 35mm cell culture dishes were incubated for
30min in 500mlo fC a
2+,M g
2+ free PBS containing
25mM Hepes, 5U/ml of activated SLO and 300nM of
each MB type. Cells were then resealed by adding 1.5ml
of the typical growth medium and incubated for 15min at
378C before performing ﬂuorescence microscopy imaging.
Fluorescent in situ hybridization and simultaneous labeling
The ﬂuorescent in situ hybridization (FISH) of mRNA
was carried out according to general procedure (24,25).
Inﬂuenza A virus-infected MDCK cells in dishes were
ﬁxed with 4% paraformaldehyde in 1  PBS, pH 7.4at
room temperature for 20min. After washing two times,
cells were permeabilized using 0.5% (v/v) Triton-x-100
in PBS for 2min followed by one PBS wash. Then cells
were dehydrated in 75% ethanol overnight at 48C. Next,
the samples were rehydrated using 2  SSC, 50% forma-
mide for 5min and then incubated with the hybridization
mixture containing 2  SSC, 1mg/ml of tRNA, 10% dex-
tran sulfate, 50% formamide, 0.01% BSA, 20U/ml ribo-
nuclease inhibitor and 500nM of probes. After 4–16h
4914 Nucleic Acids Research, 2008, Vol. 36, No. 15incubation at 378C, cells were washed two times for 20min
with 50% formamide, 2  SSC and one time with 0.5 
SSC for 10min at room temperature. Simultaneous label-
ing of NS1, TAP protein and inﬂuenza A virus mRNAs
were performed according to the protocol described pre-
viously (26). In brief, the infected MDCK cells were live-
cell labeled with the inﬂuenza A virus mRNA speciﬁc MB.
Thirty minutes after MB hybridization, cells were ﬁxed
with 4% formaldehyde in PBS for 15min at room tem-
perature, permeabilized in 0.2% Triton X-100 for 3min at
room temperature and preincubated with 2% BSA/PBS
for 45min at room temperature. They were then washed
and incubated with anti-NXF1 antibody (Abcam,
Cambridge, MA, USA) or anti-NS1 antibody for 60min
at 378C. After washing, the cells were then incubated with
FITC-labeled secondary antibody (Boster, Wuhan, China)
for 1h at 378C. Finally, the cells were washed three times
and stained with Hoechst for direct observation.
Image acquisition, datacollection and analysis
All confocal-FRAP (ﬂuorescence recovery after photo-
bleaching) experiments were made using a TCS SP2
Leica laser scanning spectral confocal microscope
equipped with a cooled CCD camera. For live-cell imag-
ing, the prepared cell culture dishes were placed in a tem-
perature-controlled incubator at 37 or 238C and detection
was made using a 100  oil objective (NA 1.32) with a
488nm excitation beam. FRAP experiments were carried
out with the standard Leica FRAP software (the advanced
time-lapse software). The 488nm lasers were set at 25% for
imaging and 100% for bleaching. The nucleus was
bleached for 4s and the cytoplasm was bleached for 6s.
In addition, cells were scanned in 2D in time, with a
pinhole setting of 2.4 airy. The diﬀusion coeﬃcients
(D-values) were calculated as described previously (27).
Except for the FRAP experiments, all imaging experiments
were carried out using an inverted wide-ﬁeld ﬂuorescent
microscope (Axiovert 200, from Carl Zeiss, Germany)
equipped with a cooled CCD camera (Model Cascade
512B, Photometrics, Tucson, AZ, USA). A ﬁlter set with
472/30nm for excitation, 510nm for dichroic beam splitter
and 520/35nm for emission viewed the green ﬂuorescence
from the EGFP channel. The red ﬂuorescence from the
TAMRA channel was viewed with an excitation ﬁlter of
531/40nm, a dichroic beam splitter of 600nm and an emis-
sion ﬁlter of 593/40nm, while the blue ﬂuorescence of
Hoechst 33258 was viewed with an excitation ﬁlter of
365nm, a dichroic beam splitter of 395nm and an emission
ﬁlter of 420nm (All ﬁlters are from Semrock, Rochester,
NY, USA). In the double-labeling experiment, GFP and
TAMRA were sequentially scanned to avoid cross talk.
Image acquisition and analysis was performed using
MetaMorph 6.0 software (Molecular Devices,
Downingtown, PA, USA). And images were further ana-
lyzed using ImageJ (NIH) v.1.33u and Adobe Photoshop.
For colocalization analysis, the merged images were used
for measuring the colocalization coeﬃcients, M1 and M2,
the Pearson’s correlation coeﬃcients, Rp and the overlap
coeﬃcients, R by the ImageJ (NIH) v.1.33u software
according to the manufacturer’s instructions and the meth-
ods, as previously described (28).
Immunoprecipitation experiments and influenza A virus
mRNAdetection
The immunoprecipitation experiments were performed as
described before (29) and the inﬂuenza virus-infected cell
nuclear extracts were used for coimmunoprecipitation
with NS1 or TAP protein by anti-NS1 or anti-TAP anti-
body. Monolayer cultures of MDCK cells or 293T cells
grown in 100mm dishes (4.8 10
6 cells) were infected with
Table 1. MBs and control probes used in this study
MB
NA mRNA MB (nucleotides 594–618)
TAMRA-GCGACTTTCAGTTATTATGCCGTTGTATTTGTCGC-DABCYL
FAM-GCGACTTTCAGTTATTATGCCGTTGTATTTGTCGC-BHQ1
M1 mRNA MB (nucleotides 526–550)
TAMRA-GCGACATGTCTGATTAGTGGGTTGGTTGTTGTCGC-DABCYL
M2 mRNA MB (nucleotides 912–936)
TAMRA-GCGACCTTCCCTCATAGACTTTGGCACTCCGTCGC-DABCYL
Random MB
TAMRA-CCAGCCTACAAACTAGCATTCTGGTGAGCTGG-DABCYL
Control probes (without 3’ quencher)
NA mRNA control probe (nucleotides 594–618)
TAMRA-GCGACTTTCAGTTATTATGCCGTTGTATTTGTCGC
M1 mRNA control probe (nucleotides 526–550; 203–227)
TAMRA-GCGACATGTCTGATTAGTGGGTTGGTTGTTGTCGC M1 (526–550)
FAM-GCGACCGGTGAGCGTGAACACAAATCCTAAGTCGC M1-2 (203–227)
M2 mRNA control probe (nucleotides 912–936)
TAMRA-GCGACCTTCCCTCATAGACTTTGGCACTCCGTCGC
All sequences are listed from their 50 end to their 30 end. The underlined bases are bases added to create the stem
domain of MBs. The nucleotides numbers of NA, M1 and M2 mRNA-speciﬁc MBs refer to positions in the NA
mRNA sequence (accession number NC_002018) and M1 mRNA sequence (accession number NC_002016). The
random MB that can not bind the mRNAs of inﬂuenza A virus [A/PR/8/34 (H1N1)] was used to verify the
speciﬁcity of the MBs designed to target inﬂuenza A virus mRNAs in infected cells.
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after infection, the medium was removed and the mono-
layers were rinsed with cold PBS, overlaid with 1ml per
dish of cell lysis buﬀer [100mM KCl, 5mM MgCl2,
10mM Hepes, pH 7.0, 0.5% NP-40, 1mM TCEP,
100U/ml ribonuclease inhibitor (Takara, Dalian, China),
2mM vanadyl ribonucleoside complexes solution (Sigma),
25ml/ml protease inhibitor mixture for mammalian tissues
(Sigma)] and the cells were detached by scraping with a
cell scraper and the cell lysate was transferred to a tube on
ice. After incubation for 10min at 48C, the cultures were
centrifuged at 5000r.p.m. for 5min and the supernatants
were considered to be the cytoplasmic fraction while the
pellet was the nuclear fraction. Then the pellet was resus-
pended in 500ml of cold high salt lysis buﬀer [400mM
KCl, 5mM MgCl2, 10mM Hepes, pH 7.0, 0.5% NP-40,
1mM DTT, 100U/ml ribonuclease inhibitor, 2mM vana-
dyl ribonucleoside complexes solution, 25ml/ml protease
inhibitor cocktail (Sigma)] and the tubes were vigorously
rocked at 48C for 45min on a shaking platform. The
supernatant was saved as nuclear extract after centrifuga-
tion at 10000 g for 30min and used for the immunopre-
cipitation experiments.
For immunoprecipitation analysis, the nuclear extracts
were precleared by incubation with 35ml of protein A agar-
ose beads at 48C for 1h with gently rotation. After centri-
fugation at 2500r.p.m. for 5min, the supernatant was
collected and incubated with 2ml of the anti-NS1 or anti-
TAP antibody at 48C overnight. Then 60ml of protein
A agarose beads was added to each tube and the tubes
were rotated at 48C for 3h. Then the beads were washed
four times with cell lysis buﬀer and were separated into two
aliquots. One of them was used for detection of inﬂuenza
A virus mRNAs and the other one was used for protein
analysis. The RNA present in the immunoprecipitates was
extracted as described before (29), and the isolated RNA
pellet was resuspended in 45ml of nuclease-free water
and analyzed with the One Step RT–PCR kit (Takara)
using primers speciﬁc for either inﬂuenza A virus NA,
M1 and PB1 mRNA or cellular b-actin and H2a mRNA.
The following primers were used: NA-Forward,
TACAGCAAAGACAATAGCATA and NA-Reverse,
CCAAACACCATTACCATACCT; corresponding to
NA mRNA (NC_002018) sequences 273–293 and 1029–
1049, respectively; M1-Forward, ACCGTGCCCAGTGA
GCGAGGA and M1-Reverse, ATGTCTGATTAGT
GGGTTGGT; corresponding to M1 mRNA
(NC_002016) sequences 224–244 and 530–550, respec-
tively; PB1-Forward, ACCGAAACTGGAGCACCGCA
and PB1-Reverse, TGTTCAGGGTCAATGCTCTA; cor-
responding to PB1 mRNA (EF467819) sequences 199–218
and 681–700, respectively; Actin-Forward, AGCGG
GAAATCGTGCGTGAC and Actin-Reverse, CGTC
ATACTCCTGCTTGCTG; corresponding to b-actin
mRNA (NM_001101) sequences 698–717 and 1155–1174,
respectively. H2a-Forward, ATGTCTGGACGAGGG
AAG and H2a-Reverse, ACTTGCTTTGGGCTT
TATGG; corresponding to H2a mRNA (NM_170745)
sequences 36–53 and 410–429, respectively. A portion of
the immunoprecipitated sample was also subjected to SDS-
polyacrylamide gel electrophoresis for analysis of bound
proteins. The proteins were detected by western blotting
with anti-NS1 or anti-TAP antibody.
RESULTS
Visualizing influenza A virus mRNAin livingMDCK cells
To visualize inﬂuenza A virus mRNA in living cells, MBs
were delivered into inﬂuenza virus-infected MDCK cells
by SLO at various time points postinfection (p.i.). NA
mRNA (intronless), M1 mRNA (intron-containing but
unspliced) and M2 mRNA (produced by splicing) were
chosen as models for the three diﬀerent types of inﬂuenza
A virus mRNAs and visualized in living host cells using
three speciﬁc MBs (NA, M1 and M2) (Table 1). First, NA,
M1 and M2 MBs were delivered into inﬂuenza A virus-
infected MDCK cells at 3.5h p.i., and the resulting ﬂuo-
rescence signals were observed under TAMRA excitation
(543nm) about 1h after beacon delivery. As shown in
Figure 1A–C, the MB ﬂuorescence signals that repre-
sented inﬂuenza A virus NA, M1 and M2 mRNAs at
4.5h p.i. appeared in both the nucleus and the cytoplasm,
and the ﬂuorescence signals in the cytoplasm mainly
appeared with a granular morphology. Noninﬂuenza
virus-infected MDCK cells showed little ﬂuorescence
60min after the addition of SLO and MB mixture
(Figure 1D), and still had very low ﬂuorescence 1.5h
after MB delivery. Moreover, when control probes, with-
out the 30 quencher, were added into noninﬂuenza virus-
infected MDCK cells, the ﬂuorescence signals were found
to be distributed mainly in the nuclei of living MDCK
cells without obvious cytoplasmic distribution
(Figure 1E), indicating that MB molecules in noninfected
cells and the excessive MBs in inﬂuenza virus-infected cells
could both distribute in cell nuclei. Many studies have
reported that both oligonucleotides and MBs can be
rapidly taken up by the nucleus, although the mechanism
is not well understood (16,20,30). These results ensured
that the ﬂuorescent signals in the nucleus and cytoplasm
of inﬂuenza virus-infected cells really came from the hybri-
dization of mRNA with MBs, and were not caused by the
degradation of MBs.
To explore the mechanisms of inﬂuenza virus mRNA
export, MBs were delivered into inﬂuenza A virus-infected
MDCK cells at diﬀerent p.i. time points and the ﬂuores-
cence signals were observed at 1.5, 2.5, 3.5, 4.5, 5.5, 6.5h
p.i. (Figure 2). At 1.5h p.i., the ﬂuorescence signals were
very weak and only found in the nucleus (Figure 2A–C).
The ﬂuorescence signals in the cytoplasm and in the
nucleus became stronger from 2.5h p.i. to 4.5h p.i.
After that, from 5.5h p.i., the ﬂuorescence signals
became weaker in both cytoplasm and nucleus. At 6.5h
p.i., there were virtually no ﬂuorescence signals in the
cytoplasm and signals in the nucleus also became very
weak. These diﬀerent distribution patterns may be asso-
ciated with the kinetics of mRNA synthesis and mRNA
export. To further conﬁrm the speciﬁcity of MBs designed
to target inﬂuenza A virus mRNAs, a random MB that
can not bind the mRNAs of inﬂuenza A virus [A/PR/8/34
(H1N1)] (Table 1) was delivered into inﬂuenza A virus-
infected MDCK cells at diﬀerent p.i. time points
4916 Nucleic Acids Research, 2008, Vol. 36, No. 15(Figure 2D). The cells delivered with this random MB at
indicated time points all showed very low ﬂuorescence
compared with the cells delivered with NA, M1 or M2
MB in Figure 2A–C, thereby demonstrating the high spe-
ciﬁcity of the inﬂuenza A virus mRNA-targeting MBs. As
shown in Figure 2E, the average ﬂuorescence intensity of
M1 MB per unit area of infected cells at diﬀerent p.i. time
points was calculated by MetaMorph 6.0 software
(Molecular Devices, USA) and the bar chart of average
ﬂuorescence intensity, averaged from 20 repeats, showed
the ﬂuorescence intensity peak of M1 mRNA was between
3.5h and 4.5h p.i. It has been reported that the synthesis
of segment 7-speciﬁc mRNA showed a peak at 4h p.i. and
continued later at a slower rate (31), which may explain
why the ﬂuorescence signals appeared strongest at about
4h p.i. (between 3.5 and 4.5h p.i.). There was little diﬀer-
ence among the ﬂuorescence distribution patterns of NA,
M1 and M2 mRNAs at indicated p.i. time points.
To corroborate the live-cell imaging results, FISH
assays were performed targeting inﬂuenza A virus NA,
M1 and M2 mRNAs in ﬁxed inﬂuenza virus-infected
MDCK cells. As shown in Figure 3A–C, the ﬂuorescence
images obtained from the FISH assay of NA, M1 and M2
mRNAs in inﬂuenza virus-infected MDCK cells at 4.5h
p.i. showed a localization pattern similar to the live-cell
imaging results, shown in Figure 1A–C. To further test
whether the MBs can be speciﬁcally hybridized to target
viral mRNAs in inﬂuenza A virus-infected cells, FISH
experiments were performed using MBs and FAM-labeled
probes targeting diﬀerent regions of inﬂuenza A virus
mRNAs (Table 1). Figure 3D shows that the M1 MBs
and M1 control probe, which target diﬀerent regions of
M1 mRNA, were colocalized in ﬁxed inﬂuenza A virus-
infected MDCK cells at 4.5h p.i. Although some noise–
signal from the M1 control probe was occasionally found
in the nucleus of noninfected cells, there was very low
signal from M1 MBs in noninfected cells (Figure 3E).
Together, these results show that MBs could be speciﬁ-
cally hybridized to inﬂuenza A virus mRNAs and used for
viral mRNA imaging in inﬂuenza A virus-infected cells.
Dynamic character of influenza Avirus mRNA inside
thenucleus and thecytoplasm
To study the dynamic character of inﬂuenza A virus
mRNA inside virus-infected MDCK cells, confocal-
FRAP (Fluorescence recovery after photobleaching)
experiments were performed. Most inﬂuenza A virus
mRNAs are intronless, so we studied the mobility char-
acteristics of intronless NA mRNA to explore if there
were diﬀerences between inﬂuenza A virus mRNAs and
cellular intron-containing mRNAs. First, the kinetic
behaviors of NA mRNA in both nucleoplasm and cyto-
plasm were studied by FRAP at 378C. FRAP images of
typical acquisitions in nucleoplasmic and cytoplasmic
areas of virus-infected MDCK cells, delivered with
FAM-labeled NA MBs 2h p.i., are shown in Figure 4A
and B. After the mean intensity of the regions of interest
were recorded and quantiﬁed for a series of FRAP images,
recovery curves averaged from six repeats were drifted
and the mobile fractions and diﬀusion coeﬃcients were
calculated (Figure 4E and F). The results of NA mRNA
in the nucleus at 378C showed that the t1/2 of recovery
was about 22s, and the diﬀusion coeﬃcient (D) was
0.027mm
2/s. However, the recovery was slightly slower
Figure 1. Imaging inﬂuenza A virus mRNA in living inﬂuenza virus-infected MDCK cells. (A–C) Inﬂuenza A virus NA, M1, M2 mRNAs, detected
with TAMRA-labeled MBs in inﬂuenza A virus-infected MDCK cells at 4.5h p.i., were found in both the nucleus and cytoplasm. (D) Control
noninfected MDCK cells show no obvious ﬂuorescence after being delivered with NA MBs. (E) Control probe of NA mRNA shows concentrated
ﬂuorescence signals in the nucleus after being delivered into noninfected MDCK cells. Bars, 10mm.
Nucleic Acids Research, 2008, Vol. 36, No. 15 4917in the cytoplasm: t1/2 was about 30s, D-value was
0.018mm
2/s (Table 2). The lower diﬀusion rate of NA
mRNA in the cytoplasm compared with that in the
nucleus may due to the association of NA mRNA with
cytoplasmic microtubules and the anchoring of NA
mRNA on the ER membrane for translation.
Furthermore, it was found that the ﬂuorescence in both
nucleus and cytoplasm during FRAP experiments could
only recover about 50% of the initial ﬂuorescence inten-
sity. These results suggested that about 50% of NA
mRNA could diﬀuse freely while the remaining 50%
appeared relatively immobile or diﬀused very slowly.
To investigate whether the transport of inﬂuenza A
virus mRNA was energy dependent or not, FRAP experi-
ments were also performed for inﬂuenza A virus NA
mRNA in inﬂuenza A virus-infected MDCK cells main-
tained at 238C, according to methods previously described
(27,32). Images of typical acquisitions are shown in
Figure 4C and D. The recovery curves, each averaged
from six repeats, showed a slower recovery of ﬂuorescence
in both nucleus and cytoplasm at 238C compared with
378C (Figure 4E and F). Signiﬁcantly, not >30% ﬂuores-
cence recovery was measured in both nucleus and cyto-
plasm at 238C. Furthermore, the recovery rate appeared a
little slower: t1/2 30s, D 0.013mm
2/s in the nucleus;
t1/2 35s, D 0.009mm
2/s in the cytoplasm (Table 2).
This result clearly indicates that the mobility of inﬂuenza
A virus intronless NA mRNA is sensitive to temperature
conditions and may suggest that the intracellular trans-
port of inﬂuenza A virus mRNA also requires energy.
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Figure 2. Visualizing inﬂuenza A virus mRNAs in living inﬂuenza virus-infected MDCK cells at diﬀerent p.i. time points. (A) NA mRNA was
detected with TAMRA-labeled MBs delivered into inﬂuenza A virus-infected MDCK cells at diﬀerent time p.i. (B) M1 mRNA was detected with
TAMRA-labeled MBs delivered into inﬂuenza A virus-infected MDCK cells at diﬀerent time p.i. (C) M2 mRNA was detected with TAMRA-labeled
MBs delivered into inﬂuenza A virus-infected MDCK cells at diﬀerent time p.i. (D) The random control MB was delivered into inﬂuenza A virus-
infected MDCK cells at diﬀerent time p.i. and showed very low ﬂuorescence at indicated time points. (E) The average ﬂuorescence intensity of M1
MBs at diﬀerent time points, p.i., is indicated by the bar chart. The average ﬂuorescence intensity was measured by MetaMorph 6.0 software
(Molecular Devices, USA) to calculate average intensity per unit area of cells in integrated cell regions of diﬀerent images (n>20). The integrated cell
regions including cell nucleus and cytoplasm were selected and manually traced by MetaMorph 6.0. All the images were acquired with an exposure
time of 5000ms and a g-value of 1.5. Bars, 10mm.
4918 Nucleic Acids Research, 2008, Vol. 36, No. 15To further establish that the mobility of inﬂuenza A virus
mRNA is mediated by active process, we reduced ATP
levels by treating cells with 10mM sodium azide plus
20mM 2-deoxyglucose in the absence of glucose for 15–
30min. Then FRAP experiments were performed at 378C
and the recovery curves, each averaged from six repeats,
showed only about 20% ﬂuorescence recovery in both
nucleus and cytoplasm (Figure 4G and H). Furthermore,
the recovery rate appeared signiﬁcantly slower: t1/2 30s,
D 0.014mm
2/s in the nucleus; t1/2 38s, D 0.008mm
2/s
in the cytoplasm (Table 2). Thus, the results in Figure 4E–
H together clearly indicate that active transport processes
may be responsible for the transport of inﬂuenza A virus
mRNAs in living cells.
ActDtreatmentcouldinhibitinfluenzaAvirusmRNAexport
in livingcells
It is well established that inﬂuenza A virus replication
depends on the function of host cell RNAP-II. Some
drugs that can inhibit the functions of RNAP-II, such as
DRB and ActD, have been reported to inhibit inﬂuenza A
virus segment 7 mRNA export from cell nucleus (25).
Here, we investigated the eﬀect of ActD treatment on
inﬂuenza A virus mRNA export in living cells. First,
MDCK cells were infected by PR/8 virus with a MOI of
1.0–10.0, and ActD was added at 1.5h p.i. Cells were then
delivered with M1 MB by SLO at 3.5h p.i., and imaged at
4.5h p.i. As shown in Figure 5A and B, M1 mRNA
distributed in both the cytoplasm and the nucleus of the
untreated cells, while in cells treated with ActD, M1
mRNA was only located in the nucleus, particularly in
the perinucleoli area. This result showed that ActD largely
blocked the nuclear export of M1 mRNA. Furthermore,
after 2h of treatment with ActD, the nuclear export of
inﬂuenza A virus intronless NA mRNA was also inhibited
and NA mRNA also concentrated in the nucleoli cap
(Figure 5C and D). This suggests that the nucleocytoplas-
mic transport of both inﬂuenza A virus intron-containing
and intronless mRNAs should be related to the function
of RNAP-II. As the viral NS1 protein was reported
involved in cellular intron-containing mRNA splicing
and nuclear export, we also examined its cellular distribu-
tion in ActD-treated MDCK cells to investigate if it was
also associated with inﬂuenza A virus mRNAs. Inﬂuenza
A virus-infected MDCK cells were treated with ActD
from 1.5 to 3.5h p.i., and the cells observed following
immunoﬂuorescence analysis of viral NS1 protein. As
shown in Figure 5E and F, after 2h treatment of ActD,
NS1 was concentrated in the peri-nucleoli area, which was
very similar to the localization of inﬂuenza A virus NA
and M1 mRNAs after ActD treatment. Besides that, the
levels of NS1 in the nucleoplasm were largely decreased
compared with that in nondrug-treated cells, which indi-
cates that the import of NS1 was also inhibited by ActD
treatment. The relocalization of NS1 protein after ActD
treatment might also relate to the inhibition eﬀect of
ActD on inﬂuenza A virus mRNA export.
Influenza Avirus mRNA export might notdependon the
function ofCRM1
CRM1, an evolutionarily conserved protein, is a receptor
for leucine rich nuclear export signal-dependent protein
transport and is also involved in mRNA export in eukary-
otic cells (33). In addition, CRM1 is also involved in some
viral mRNA export, such as HIV mRNA nucleocytoplas-
mic transport mediated by REV protein (34,35). In this
study, using LMB to inhibit the function of CRM1 in
living cells, we investigated the role of CRM1 in inﬂuenza
A virus mRNA export. First, MDCK cells were infected by
PR/8 virus with a MOI of 1.0–10.0, and LMB then added
at 0.5h p.i. At 3.5h p.i., cells were delivered with M1 MBs
by SLO, and were imaged at about 4.5h p.i. As shown in
Figure 6A and B, M1 mRNA distributed in both nucleus
and cytoplasm after LMB treatment, in the same way
as in nondrugs-treated cells. This indicates that the
nucleocytoplasmic transport of inﬂuenza A virus M1
mRNA could not be inhibited by LMB treatment.
In addition, LMB inhibition of inﬂuenza A virus intronless
NA mRNA also showed that the NA mRNA distribution
in LMB-treated MDCK cells was not signiﬁcantly diﬀerent
compared with that in untreated cells (Figure 6C and D).
Hence, the nucleocytoplasmic transport of inﬂuenza A
virus NA mRNA was not aﬀected by the inhibition of
CRM1. Moreover, immunoprecipitation experiments of
CRM1 protein were performed in vitro, and showed that
inﬂuenza A virus NA and M1 mRNA could not be
detected in the coimmunoprecipitation samples (data not
shown). The results indicate that there was no obvious
Figure 3. Localization of NA, M1 and M2 MBs in inﬂuenza A virus-
infected MDCK cells by FISH. (A–C) Localization of NA, M1 and M2
MBs in inﬂuenza A virus-infected MDCK cells at 4h p.i. by FISH.
(D) Colocalization of M1 MBs and M1 control probes in inﬂuenza
virus-infected MDCK cells at 4h p.i. by FISH. (E) Low ﬂuorescence
background of M1 MBs in nonvirus-infected MDCK cells at 4h p.i. by
FISH. Bars, 10mm.
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Figure 4. Diﬀusion dynamics of inﬂuenza A virus NA mRNA as revealed by FRAP in inﬂuenza virus-infected MDCK cells. Confocal-FRAP
measurements were carried out in inﬂuenza virus-infected MDCK cells using a 100 objective at 3h p.i. (A and B) Serial FRAP images of NA mRNA
at 378C in inﬂuenza virus-infected MDCK cells. (C and D) Serial FRAP images of NA mRNA at 238C in inﬂuenza virus-infected MDCK cells.
(E) Typical recovery curves (n=6) of the FRAP measurements of NA mRNA in inﬂuenza virus-infected MDCK cell nuclei at 23 and 378C,
respectively. (F) Typical recovery curves (n=6) of the FRAP measurements of NA mRNA in inﬂuenza virus-infected MDCK cell cytoplasm at 23
and 378C, respectively. (G) Typical recovery curves (n=6) of the FRAP measurements of NA mRNA in inﬂuenza virus-infected MDCK cell nuclei
at 378C after ATP depletion. (H) Typical recovery curves (n=6) of the FRAP measurements of NA mRNA in inﬂuenza virus-infected MDCK cell
cytoplasm at 378C after ATP depletion. The bleached areas are indicated by arrowheads and rectangles. Bars, 10mm.
4920 Nucleic Acids Research, 2008, Vol. 36, No. 15physical association between CRM1 and inﬂuenza A virus
NA and M1 mRNAs. Together, these results suggest that
the nuclear export of intron-containing and intronless
inﬂuenza A virus mRNAs may not depend on the CRM1
pathway of the host cell.
Allthree types of influenza A virus mRNAcould
colocalize withNS1 proteinin thenucleus
Inﬂuenza A virus NS1 protein can inhibit the splicing and
nucleocytoplasmic transport of cellular mRNA and might
also play roles in the splicing and transport of viral intron-
containing NS1 mRNA (2,14,36–38). Our experiments
above showed that NS1 protein and inﬂuenza A virus
mRNA concentrated in the nucleolar cap in ActD-treated
MDCK cells. Here, combining the live-cell imaging of
both viral mRNAs and NS1 protein in inﬂuenza A
virus-infected MDCK cells, we investigated the associa-
tion between NS1 protein and inﬂuenza A virus
mRNAs. First, the MDCK cells were transiently trans-
fected with plasmid pEGFP-C1-NS1, which contains the
coding sequence for NS1 protein. Sixteen hours after
transfection, the MDCK cells were infected with PR/8
virus at a MOI of 1.0–10.0. MBs were then delivered
into the inﬂuenza virus-infected cells by SLO at 3.5h p.i.
About 1h after MB transfection, the ﬂuorescence of NS1
protein and MBs hybridized with inﬂuenza A virus
mRNAs were imaged in the same cells. As shown in
Figure 7A–C, inﬂuenza A virus NA, M1 and M2
mRNAs were all colocalized with NS1 protein in the
Table 2. Diﬀusion times and coeﬃcients measured for inﬂuenza A virus
NA mRNA
Samples t1/2 recovery (s) D (mm
2/s)
NA mRNA (378C)
in nucleus
22 0.027 0.016
NA mRNA (378C)
in cytoplasm
30 0.018 0.003
NA mRNA (238C)
in nucleus
30 0.013 0.007
NA mRNA (238C)
in cytoplasm
35 0.009 0.003
NA mRNA (378C)
in nucleus—ATP depleted
30 0.014 0.005
NA mRNA (378C) in
cytoplasm—ATP depleted
38 0.008 0.003
Values for t1/2 and D were determined as described in Materials and
methods section.
D-values represent mean SEM.
Figure 5. ActD treatment could inhibit inﬂuenza A virus mRNA export and change virus mRNA localization. (A and B) MDCK cells were infected
with PR/8 and incubated without drug or with ActD from 90min p.i., until 3.5h p.i. when they were delivered with M1 MBs for inﬂuenza virus M1
mRNA detection. (C and D) MDCK cells were infected with PR/8 and incubated without drug or with ActD from 90min p.i., until 3.5h p.i. when
they were delivered with NA MBs for inﬂuenza virus NA mRNA detection. (E and F) Distribution of viral NS1 protein in ﬁxed inﬂuenza virus-
infected MDCK cells without drug or with 2h ActD treatment. The nucleoli cap positions are indicated by arrowheads. Bars, 10mm.
Nucleic Acids Research, 2008, Vol. 36, No. 15 4921nucleus. The colocalization coeﬃcients were measured by
software ImageJ (NIH) v.1.33u according to methods pre-
viously described (28), and the high Pearson’s correlation
coeﬃcients indicated good colocalization (Table 3). The
colocalization of NS1 protein and M2 mRNA might be
correlated with NS1 inhibition of the splicing and export
of intron-containing mRNAs, but the colocalization of
intronless NA mRNA with NS1 protein was very surpris-
ing. Simultaneous labeling of both NA mRNA and NS1
protein in ﬁxed inﬂuenza Avirus-infectedMDCKcellswas
also carried out to conﬁrm the results of the live-cell ima-
ging. Thirty minutes after live-cell MB hybridization with
NA mRNA, cells were ﬁxed and NS1 protein was labeled
by immunoﬂuorescence. As shown in Figure 7D, the NA
mRNAcould alsobefound colocalized withNS1in thecell
nucleus of ﬁxed inﬂuenza A virus-infected MDCK cells.
Furthermore, as expected, the M1 and M2 mRNAs could
alsobe colocalized with NS1 protein in ﬁxed MDCK nuclei
(data not shown). As a control, there was very little signal
of both inﬂuenza A virus NA mRNA and NS1 protein in
ﬁxednonvirus-infectedMDCKcells(Figure7E).Together,
these results show that not only intron-containing but also
intronless mRNA of inﬂuenza A virus may interact with
NS1 protein in cell nucleus.
Allthree types of influenza A virusmRNA could colocalize
withcellular TAP proteinin thenucleus
We discussed above that CRM1 may not be involved in
inﬂuenza A virus mRNA export, so inﬂuenza A virus
mRNAs may utilize another cellular mRNA export path-
way, the TAP/p15 pathway. TAP protein is a very impor-
tant factor involved in cellular mRNA export and some
virus mRNA export (3–5,39). Inﬂuenza A virus spliced
NS2 and M2 mRNA may be able to use the standard
EJC/TAP-p15-dependent mRNA export pathway, just as
cellular intron-containing mRNAs do (2). To further
uncover the roles of TAP protein in inﬂuenza A virus
mRNA export, especially intronless mRNA export, we
visualized the cellular localization of inﬂuenza A virus
mRNA and TAP protein in same living inﬂuenza A
virus-infected MDCK cells. First, the MDCK cells were
transiently transfected with plasmid pCDNA3.1-TAP-
GFP, which contains the TAP coding sequence. Sixteen
hours after transfection, the MDCK cells were infected
with PR/8 virus and delivered with NA, M1 or M2 MBs
by SLO at 3.5h p.i. As shown in Figure 8A–C, the three
kinds of inﬂuenza A virus mRNA, including the intronless
NA mRNA, could all colocalize with TAP protein in the
nucleus. The colocalization was also analyzed quantita-
tively using software ImageJ (NIH) v.1.33u (Table 3). As
in living cells, the inﬂuenza virus mRNA could be found
colocalized with TAP protein in ﬁxed inﬂuenza A virus-
infected MDCK cells (Figure 8D). In noninfected MDCK
cells, there was obvious signal of TAP protein and only
very little background signal from NA mRNA in ﬁxed
cell nuclei (Figure 8E). These results indicate that TAP
protein may interact with both intron-containing and
intronless mRNAs of inﬂuenza A virus in cell nucleus.
Coimmunoprecipitation of influenza A virusmRNAs
with NS1or TAP protein
To ﬁnd more direct evidence that NS1 or TAP protein were
involved in the transport of inﬂuenza A virus mRNAs,
immunoprecipitation experiments of mRNA–protein com-
plexes were performed using anti-NS1 and anti-TAP anti-
bodies. For this analysis, nuclear extracts were prepared
from inﬂuenza A virus-infected MDCK cells at 5h p.i. and
immunoprecipitated with anti-NS1 antibody. The RNA
extracted from the immunoprecipitation samples was
used for RT–PCR analysis of the presence of inﬂuenza A
virus NA, M1 and PB1 mRNAs. The results in Figure 9A
and B indicated that inﬂuenza A virus NA, M1 and PB1
mRNA could be detected from the infected coimmunopre-
cipitation sample pulled down by anti-NS1 antibody but
not from the sample pulled down by control antibody.
There was also no inﬂuenza A virus mRNA present in
the noninfection coimmunoprecipitation samples pulled
down by anti-NS1 antibody. In contrast, not cellular
intronless H2a mRNA but spliced b-actin mRNA was
detected from the infected coimmunoprecipitation sample
pulled down by anti-NS1 antibody (Figure 9A and B).
The association of NS1 protein with spliced b-actin
Figure 6. Inﬂuenza virus mRNA export was not dependent on CRM1. (A and B) MDCK cells were infected with PR/8 and incubated without drug
or with LMB from 30min p.i., until 3.5h p.i. when they were delivered with M1 MBs for inﬂuenza virus M1 mRNA detection. (C and D) MDCK
cells were infected with PR/8 and incubated without drug or with LMB from 30min p.i., until 3.5h p.i. when they were delivered with NA MBs for
inﬂuenza virus NA mRNA detection. Bars, 10mm.
4922 Nucleic Acids Research, 2008, Vol. 36, No. 15mRNA may be due to the interaction of NS1 protein with
splicing complexes in cell nucleus. Nuclear extracts were
also prepared from inﬂuenza A virus-infected 293T cells at
5h p.i. and immunoprecipitated with anti-TAP antibody
to investigate the association of inﬂuenza A virus mRNA
with TAP. And as shown in Figure 9D and E, the results
were very similar to that of coimmunoprecipitation by
anti-NS1 antibody. Inﬂuenza A virus NA, M1 and PB1
mRNA could only be detected from the infected coimmu-
noprecipitation sample pulled down by anti-TAP anti-
body. There were no inﬂuenza A virus NA, M1 and PB1
mRNAs in noninfection or negative control coimmuno-
precipitation samples. As control, cellular spliced b-actin
mRNA and intronless H2a mRNA which were reported to
be exported by TAP/p15 pathway (40), could all be
detected from the infected or noninfected coimmunopreci-
pitation samples pulled down by anti-TAP antibody.
Moreover, the presence of NS1 or TAP protein pulled
Figure 7. Colocalization of inﬂuenza A virus mRNA with NS1 protein in inﬂuenza virus-infected MDCK nuclei. (A–C) NA, M1 and M2 mRNAs could
colocalize with NS1 protein in living inﬂuenza A virus-infected MDCK cells. (D) NA mRNA could colocalize with NS1 protein in ﬁxed inﬂuenza A virus-
infected MDCK cells. (E) Low ﬂuorescence background of NA mRNA and NS1 protein in ﬁxed nonvirus-infected MDCK cells. Bars, 10mm.
Table 3. Colocalization and correlation coeﬃcients for inﬂuenza A
virus mRNAs with viral NS1 protein and cellular TAP protein
a
Objects M1
b M2
c Rp
d R
e
NA mRNA and NS1 protein 0.448 0.923 0.696 0.708
M1 mRNA and NS1 protein 0.622 0.966 0.718 0.767
M2 mRNA and NS1 protein 0.440 1.000 0.440 0.542
NA mRNA and TAP protein 0.851 0.927 0.936 0.944
M1 mRNA and TAP protein 0.352 0.998 0.740 0.732
M2 mRNA and TAP protein 1.000 0.655 0.953 0.945
aThe colocalization of inﬂuenza A virus mRNAs with NS1 protein or
TAP protein was analyzed using ImageJ (NIH) v.1.33u software as
described in Materials and methods section.
bThe colocalization coeﬃcients for red channel (NA, M1 or M2
mRNA).
cThe colocalization coeﬃcients for green channel (NS1 protein or TAP
protein).
dThe Pearson’s correlation coeﬃcients for each object colocalization.
eThe overlap coeﬃcients for each object colocalization.
Nucleic Acids Research, 2008, Vol. 36, No. 15 4923down by anti-NS1 antibody or by anti-TAP antibody in
infected coimmunoprecipitation samples was conﬁrmed by
western blot analysis, as shown in Figure 9C and F. These
results further conﬁrmed that inﬂuenza A virus NA, M1
and PB1 mRNAs could all be associated with inﬂuenza A
virus NS1 protein and cellular TAP protein in cell nucleus.
DISCUSSION
Elucidating the dynamic behaviors of inﬂuenza A virus
mRNAs in living cells is crucial to better understanding
the mechanisms of its transport. In this report, by deliver-
ing speciﬁc MBs into living inﬂuenza A virus-infected
MDCK cells, inﬂuenza A virus NA, M1 and M2
mRNAs were successfully visualized in living host cells.
Consistent with previous studies, MBs were testiﬁed to
be a powerful tool for imaging viral RNA in living cells.
The reversible permeabilization of cells by SLO was also
conﬁrmed to be a good method to deliver MBs into living
cells, as previously described (23,26). The mRNA imaging
was mainly focused on the initial phase of probe uptake by
cells, within 1h, to ensure the reliability of the results, and
we also optimized the dose of MBs and the virus MOI to
improve the signal-to-background ratio. Moreover, the
MBs targeted for inﬂuenza A virus mRNA might also
detect the positive sense virus cRNA in nucleus, but the
cRNA only represents a minor proportion (5–10%) of the
total positive sense RNA in infected cells (25) and cRNA
might be encapsidated with viral NP protein (41), so the
Figure 8. Colocalization of inﬂuenza A virus mRNA with TAP protein in inﬂuenza virus-infected MDCK cell nuclei. (A–C) NA, M1 and M2
mRNAs could colocalize with TAP protein in living inﬂuenza A virus-infected MDCK cells. (D) NA mRNA could colocalize with TAP protein in
ﬁxed inﬂuenza A virus-infected MDCK cells. (E) Obvious ﬂuorescence distribution of cellular TAP protein and very low ﬂuorescence background of
virus NA mRNA in ﬁxed nonvirus-infected MDCK cells. Bars, 10mm.
4924 Nucleic Acids Research, 2008, Vol. 36, No. 15Figure 9. Coimmunoprecipitation of inﬂuenza A virus mRNAs with viral NS1 protein or cellular TAP protein. (A and B) Inﬂuenza A virus NS1 protein
was pulled down with anti-NS1 antibody from nuclear extract of inﬂuenza A virus-infected MDCK cells. Then RNA was puriﬁed from the immuno-
precipitated complexes and used for RT–PCR analysis of the presence of NA, M1 and PB1 mRNAs. Molecular size standards in kilobase are indicated to
the left. (C) Western blot analysis to show speciﬁcity of anti-NS1 antibody used in this study. All protein samples were separated by SDS–15% PAGE and
analyzed by western blotting. C: IP with control antibody in PR/8 virus-infected cell nuclear extract; PR/8: IP with anti-NS1 antibody in PR/8 virus-
infected cell nuclear extract; Mock: IP with anti-NS1 antibody in nonvirus-infected cell nuclear extract. TF: Total extract of MDCK cells transfected with
pCDNA3.1-NS1. (D–E) TAP protein was pulled down with anti-TAP antibody from nuclear extract of inﬂuenza A virus-infected 293T cells. Then RNA
was puriﬁed from the immunoprecipitated complexes and used for RT–PCR analysis of the presence of NA, M1 and PB1 mRNAs. Molecular size
standards in kilobase are indicated at the left. (F) Western blot analysis to show speciﬁcity of anti-TAP antibody used in this study. All protein samples
were separated by SDS–10% PAGE and analyzed by western blotting. C: IP with control antibody in PR/8 virus-infected cell nuclear extract; PR/8: IP
with anti-TAP antibody in PR/8 virus-infected cell nuclear extract; Mock: IP with anti-TAP antibody in nonvirus-infected cell nuclear extract. TF: Total
extract of 293T cells transfected with pCDNA3.1-TAP. The position of heavy chain of the IgG used for immunoprecipitation is indicated to the left and
the position of molecular weight marker (in kilodalton) is indicated to the right. All DNA markers were DL2000 (Takara).
Nucleic Acids Research, 2008, Vol. 36, No. 15 4925virus cRNA is unlikely to signiﬁcantly interfere with viral
mRNA detection in living cells. The distribution changes
of inﬂuenza A virus mRNA was imaged at diﬀerent p.i.
time points and the results indicated that inﬂuenza A virus
NA, M1 and M2 mRNA have a peak of production at
about 4.5h p.i. (Figure 2A–C and E), which was in concern
with the results described earlier (31).
The confocal-FRAP measurements of inﬂuenza A virus
intronless NA mRNA revealed that about 50% of NA
mRNA diﬀused freely within the nucleus and cytoplasm,
with a diﬀusion coeﬃcient ( 0.027mm
2/s) in the nucleo-
plasm similar to that of poly(A)
+ RNA ( 0.04mm
2/s)
(27). The ﬂuorescence recovery rates in the cytoplasm
were a little slower than those in nucleus, with only a
diﬀusion coeﬃcient of about 0.018mm
2/s (Figure 4A, B,
E and F). These diﬀerences of recovery rates in cytoplasm
and nucleus are very similar to those of cellular endogen-
ous RNAs (42). These diﬀerences may be due to NA
mRNA anchoring to microtubules or to the ER mem-
brane for translation in the cytoplasm, just as cellular
mRNAs with signal peptides do. FRAP experiments
with NA control probe in noninfected MDCK cells were
also performed and the results revealed the free NA con-
trol probe moved much faster through the nucleus
(D 0.22 0.06mm
2/s) compared with the NA MB in
inﬂuenza A virus-infected cells. These results strongly
indicated that the mobility characters measured by
FRAP analysis truly reﬂect the dynamic behaviors of
inﬂuenza A virus NA mRNA. In addition, we also
found that active transport may be required for intracel-
lular transport of inﬂuenza A virus intronless NA mRNA
by investigating eﬀect of low temperature and ATP deple-
tion on the mobility of NA mRNA. The very low diﬀusion
coeﬃcient (0.013mm
2/s in nucleoplasm; 0.009mm
2/s in
cytoplasm) and not >30% ﬂuorescence recovery at 238C
(see Figure 4C–F) together suggested that inﬂuenza A
virus NA mRNA transport in both nucleus and cytoplasm
is sensitive to temperature conditions. ATP depletion also
signiﬁcantly decreased the portion of mobile fraction (only
20%) and reduced the mobility of NA mRNA
(0.014mm
2/s in nucleoplasm; 0.008mm
2/s in cytoplasm)
in both nucleus and cytoplasm. Some previous researches
reported that the mobility of mRNP particles in nucleus
was not directed but was governed by simple diﬀusion
within interchromatin spaces and ATP is only required
for the complexes to resume their motion after they
become stalled at dense chromatin (42–44). The decreased
mobility of inﬂuenza A virus NA mRNA in nucleus at low
temperature might be related to the increased viscosity of
nuclei to some extent. But the ATP depletion could
decrease both mobile fraction and diﬀusion coeﬃcients
of inﬂuenza virus NA mRNA in both nucleus and cyto-
plasm was diﬀerent from that of cellular mRNP particles
described previously (42). So the transport mechanism of
inﬂuenza A virus mRNA in nucleus may diﬀer from that
of some cellular mRNP particles. In another words, the
transport of inﬂuenza A virus mRNA in both nucleus and
cytoplasm is an energy-dependent process as is that of
some poly(A)
+ RNAs reported before (27,45).
It has been reported that inﬂuenza A virus segment
7 mRNA nuclear export requires host cell RNAP-II
function (25). In this study, we also investigated the func-
tion of RNAP-II in inﬂuenza A virus mRNA export by
using ActD inhibition of RNAP-II, combined with live-
cell imaging of inﬂuenza A virus mRNAs. The nuclear
export of both intron-containing M1 mRNA and intron-
less NA mRNA were all largely blocked in living virus-
infected MDCK cells treated with ActD. Moreover, PB1
mRNA was also inhibited to some extent by ActD treat-
ment (data not shown). This suggests that the export of
both inﬂuenza A virus intron-containing mRNA and
intronless mRNA is related to the function of RNAP-II.
There may be the possibility that some cellular or viral
proteins needed for eﬃcient transport of viral mRNAs
are recruited to the mRNAs in the presence of functional
RNAPII but not in its absence. It has been reported that a
group of nucleoplasmic proteins, mostly RNA-binding
proteins, relocalize from the nucleoplasm to a speciﬁc
nucleolar cap during transcriptional inhibition (46).
Viral NS1 protein was found concentrated to the nucleoli
cap after ActD treatment in inﬂuenza virus-infected
MDCK cells and the import of NS1 was also inhibited
by ActD treatment (Figure 5E and F). The relocalization
of NS1 protein after ActD treatment might relate to the
inhibition of ActD on inﬂuenza A virus mRNAs export.
The CRM1 pathway was the ﬁrst RNA export pathway
to be elucidated, and is involved in mRNA export in
eukaryotic cells (5,33). In this study, we investigated if
the CRM1 pathway was involved in inﬂuenza A virus
mRNA export by using LMB inhibition in living cells.
The nuclear export of both inﬂuenza A virus intron-con-
taining M1 mRNA and intronless NA mRNA could
not be inhibited by LMB treatment in living cells
(Figure 5A–D). The export of intronless PB1 mRNA
also could not be blocked by LMB treatment (data not
shown). Moreover, the results of in vitro CRM1 immuno-
precipitaion indicated that CRM1 could not associate
with inﬂuenza A virus NA and M1 mRNAs (data not
shown). All these results suggest that both intron-contain-
ing and intronless inﬂuenza A virus mRNAs are exported
from MDCK cell nuclei by a CRM1 independent
pathway.
NS1 is a very important multifunctional nonstructural
protein, which can inhibit cellular intron-containing
mRNA splicing and export by binding with CPSF and
PABPII, or by forming an inhibitory complex with
TAP/p15 (1,14). Moreover, NS1 protein can also inhibit
the splicing and export of its own mRNA in an RNA
binding-dependent manner (2). In this report, we com-
bined the live-cell imaging of both inﬂuenza A virus
mRNAs and NS1 protein to explore the roles of NS1 in
the transport of inﬂuenza A virus mRNA, especially in the
export of intronless mRNAs. The results showed that NS1
could colocalize with all three types of inﬂuenza A virus
mRNA including the intronless NA mRNA (Figure 7A–
C). Simultaneous labeling of virus mRNAs and NS1
protein in ﬁxed cells further conﬁrmed colocalization.
Furthermore, inﬂuenza A virus NA, M1 and PB1
mRNAs could be coimmunoprecipitated with NS1 protein
by pull-down with anti-NS1 antibody (Figure 9A and B).
The coimmunoprecipitation experiments further testiﬁed
the association of NS1 with inﬂuenza A virus mRNA in
4926 Nucleic Acids Research, 2008, Vol. 36, No. 15the nucleus. NS1 protein was reported to interact with
inﬂuenza A viral transcription–replication complexes in
infected cells (47) and be cross-linked to inﬂuenza A
mRNAs in cytoplasm for enhancement of viral protein
translation (48,49). Recently, NS1 protein was also
found to be able to selectively bind to inﬂuenza A virus
NS1 mRNA (2). Together with our results, these might
suggest that NS1 protein could also associate with all
three kinds of inﬂuenza A virus mRNAs in the nucleus
and this association may start from the initiation of virus
transcription by ﬁrst interacting with viral transcription–
replication complexes. Moreover, the association of NS1
with inﬂuenza A virus intronless mRNAs in the nucleus
could not be simply interpreted by the inhibition of NS1
on virus mRNA, like the roles of NS1 protein in NS1 and
NS2 mRNAs export. NS1 protein might also play some
active roles in the export of virus intronless mRNAs by
promoting the recruitment of cellular mRNA transport
factors to inﬂuenza A virus intronless mRNAs. Lastly,
the roles of NS1 protein in inﬂuenza A virus mRNA trans-
port may be diﬀerent at diﬀerent infection times.
TAP/NXF1 is, to date, the most important receptor
involved in the export of mRNA from the nucleus to the
cytoplasm (12,39,50). Some DNA and RNA viruses also
use the TAP/p15 pathway to transport their own mRNA
from the nucleus to the cytoplasm, such as HSV (5). We
also investigated whether TAP protein is involved in the
nuclear export of inﬂuenza A virus mRNA. Live-cell
imaging of both inﬂuenza A virus mRNA and TAP
protein revealed that TAP could colocalize not only
with intron-containing mRNAs but also with intronless
NA mRNA (Figure 8A–C). Simultaneous labeling of
virus mRNA and TAP protein in ﬁxed cells also conﬁrmed
that TAP could colocalize with inﬂuenza A virus mRNA.
Moreover, coimmunoprecipitation of TAP protein and
inﬂuenza virus mRNPs with anti-TAP antibody indicated
physical association of TAP and inﬂuenza virus mRNA
(Figure 9D and E). Together, these data suggest the asso-
ciation of TAP protein with the three kinds of inﬂuenza A
virus mRNAs. However, considering that inﬂuenza A
virus intronless mRNAs cannot recruit TAP protein
by splicing complexes like intron-containing cellular
mRNAs do, there may be some viral or cellular factors
bridging TAP to the inﬂuenza virus intronless mRNAs,
in a similar manner to the role of ICP27 in HSV intronless
mRNA export (4). In conclusion, it was revealed that TAP
protein might be involved in inﬂuenza A virus mRNA
export by live-cell imaging and by in vitro analysis, but
how inﬂuenza A virus intronless mRNAs recruit TAP
protein and the accurate mechanisms of transport need
to be further elucidated.
In conclusion, the distribution and dynamic behaviors
of inﬂuenza A virus mRNAs in living virus-infected cells
were successfully visualized. The export of inﬂuenza A
virus mRNA was found to be independent of the CRM1
pathway, while RNAP-II is involved. Imaging analysis
and coimmunoprecipitation experiments uncovered that
inﬂuenza A virus mRNAs associate with viral NS1 and
cellular TAP protein in the nucleus. These ﬁndings suggest
that the inﬂuenza A virus mRNA may be exported from
the nucleus by the cellular TAP/p15 pathway with NS1
protein and RNAP-II participation.
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